Bioinformatics In IVD Testing Market Growth, Size, Share, Trends, and Forecast 2032

What is the Bioinformatics In IVD Testing Market Size?

According to the report published by Zion Market Research, the global Bioinformatics In IVD Testing Market size was valued at USD 97.51 Billion in 2023 and is predicted to reach USD 171.91 Billion by the end of 2032. The market is expected to grow with a CAGR of 6.44% during the forecast period. The report analyzes the global Bioinformatics In IVD Testing Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Bioinformatics In IVD Testing Market industry.

Request Free Sample

Global Bioinformatics In IVD Testing Market: Overview

Healthcare professionals depend on several tools for diagnosis of the condition and guide the decisions for the treatment. Among the most common and widely used is in vitro diagnostics (IVDs). IVDs are generally used for the analysis of human samples including saliva and blood or by detecting the absence & presence of a marker or set of markers such as immune response to an infection or genetic mutation. The use of bioinformatics in IVD enables clinical laboratory professionals to accurately diagnose the diseases.

Global Bioinformatics In IVD Testing Market: Growth Factors

The global bioinformatics in IVD testing market is growing at a rapid rate. Factors that are majorly contributing to the growth of the global market are the rise in penetration of IT in the healthcare sector, the growing prevalence of life-threatening diseases such as cancer & cardiovascular diseases, and the ability of the bioinformatics-based diagnosis to understand the epidemiology of the infection. Bioinformatics is a field of science and a sub-discipline of computer science and biology related to the acquirement, analysis, storage, and distribution of biological data. It uses several programs to determine the functioning of protein & genes, establish evolutionary relationships, and predict 3D shapes of the proteins. Hence, bioinformatics in IVD testing can help diagnose cancer and contribute to therapy management.

It also enables detection of hard to culture pathogenic viruses & bacteria and understand the epidemiology of the infections. In addition to this, the analysis of mutations of the known human genome by the use of bioinformatics can help to diagnose inherited diseases, common disorders as well as show the prognosis of malignant diseases. Thus, such a huge contribution of bioinformatics-based testing has led to the rise in the adoption of bioinformatics in IVD testing thereby surging the growth of the global bioinformatics in IVD testing market. Moreover, the rise in collaborations of the IT companies with the laboratory testing manufacturers for the development of software and algorithm for the diagnosis of diseases is also among the prime factors that are augmenting the growth of the global market.

Request Free Sample

Furthermore, technological advancements in the development of efficient products may offer several opportunities for the growth of the global bioinformatics in IVD testing market during the forecast period. However, the lack of skilled staff and high cost associated with it may hamper the growth of the global bioinformatics in IVD testing market.

The global bioinformatics in IVD testing market has witnessed rapid growth during the outbreak of the Covid-19. The coronavirus rapidly infected millions of people and thus rapid testing became an essential factor. The BioFire® COVID-19 Test is an FDA-approved test for Covid-19. In silico analysis of BioFire® COVID-19 Test was done using bioinformatics to survey all high coverage genomes from the GISAID EpiCoV database. BioFire Defense continuously monitors emerging strains/sequence variants of SARS-CoV-2 and assessing predicated assay performance. This has majorly contributed to the growth of the global market amid the pandemic situation.

Global Bioinformatics In IVD Testing Market: Segmentation

The global bioinformatics in IVD testing market is bifurcated based on the type of test, application, type, and region.

Based on the type of test, the global bioinformatics in IVD testing market is fragmented into blood based tests and tissue based tests.

Based on the application, the global market is divided into cancer, chronic diseases, cardiovascular diseases, diabetes, and others.

The type segment is split into hardware and software.

Bioinformatics In IVD Testing Market : Report Scope

Report Attributes	Report Details
Report Name	Bioinformatics In IVD Testing Market Research Report
Market Size in 2023	USD 97.51 Billion
Market Forecast in 2032	USD 171.91 Billion
Growth Rate	CAGR of 6.44%
Number of Pages	196
Key Companies Covered	Affymetrix, IBM Corporation, Medtronic Inc, Life Technologies, CardioDx Inc, Biodesix Inc, Aperico Technologies Inc, AssureRx Health Inc, Datech Oncology, and Bioreference Laboratories Inc
Segments Covered	By The type of test, By Application, By Type and By Region
Regions Covered	North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year	2023
Historical Year	2018 to 2022
Forecast Year	2024 - 2032
Customization Scope	Avail customized purchase options to meet your exact research needs. Request For Customization

Global Bioinformatics In IVD Testing Market: Regional Analysis

Regionally, North America is estimated to account for the largest share in the global bioinformatics in IVD testing market over the forecast period. The presence of the well-established IT & healthcare sector, rise in research on genomic sequences, and rapid adoption of advanced technologies are the key factors that are contributing to the remarkable growth of the market in this region. Europe is also anticipated to hold a noteworthy share in the market due to huge investments in the development of the software & algorithm required for bioinformatics-based diagnostic tools. On the other hand, Asia Pacific region is estimated to grow with a significant CAGR over the forecast period. This is due to growing awareness related to the use of biobanks and rapidly growing healthcare infrastructure.

Global Bioinformatics In IVD Testing Market: Competitive Players

• Affymetrix
• IBM Corporation
• Medtronic Inc
• Life Technologies
• CardioDx Inc
• Biodesix Inc
• Aperico Technologies Inc
• AssureRx Health Inc
• Datech Oncology
• Bioreference Laboratories Inc

are some of the key participants that are operating in the global bioinformatics in IVD testing market.

The Global Bioinformatics In IVD Testing Market is segmented as follows:

By The type of test 

• blood based tests
• tissue based tests 

By Application 

• cancer 
• chronic diseases 
• cardiovascular diseases 
• diabetes 
• and others

By Type 

• hardware
• software 

Global Bioinformatics In IVD Testing Market: Regional Segment Analysis

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.